These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38417789)

  • 21. [Spontaneous antepartal RhD alloimmunization].
    Studničková M; Holusková I; Durdová V; Kratochvílová T; Strašilová P; Marková I; Lubušký M
    Ceska Gynekol; 2015 Dec; 80(6):401-4. PubMed ID: 26741153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Practice Bulletin No. 181 Summary: Prevention of Rh D Alloimmunization.
    Obstet Gynecol; 2017 Aug; 130(2):481-483. PubMed ID: 28742667
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of anti-D immunoglobulin in the treatment of threatened miscarriage in the accident and emergency department.
    Weinberg L
    Emerg Med J; 2001 Nov; 18(6):444-7. PubMed ID: 11696491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Appropriate provision of anti-D prophylaxis to RhD negative pregnant women: a scoping review.
    Fyfe TM; Ritchey MJ; Taruc C; Crompton D; Galliford B; Perrin R
    BMC Pregnancy Childbirth; 2014 Dec; 14():411. PubMed ID: 25491600
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Guideline for prevention of RhD alloimmunizationin RhD negative women].
    Lubušký M; Procházka M; Simetka O; Holusková I
    Ceska Gynekol; 2013 Apr; 78(2):132-3. PubMed ID: 23710977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prevention of Rh immunization. I. Theoretical background and management of the risk during the first half of pregnancy].
    Larsen JF; Bock JE; Jørgensen JR
    Ugeskr Laeger; 2004 Aug; 166(36):3073-8. PubMed ID: 15387303
    [No Abstract]   [Full Text] [Related]  

  • 27. Is Rh immune globulin needed in early first-trimester abortion? A review.
    Jabara S; Barnhart KT
    Am J Obstet Gynecol; 2003 Mar; 188(3):623-7. PubMed ID: 12634631
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rhesus isoimmunisation in unsensitised RhD-negative individuals seeking abortion at less than 12 weeks' gestation: a systematic review.
    Chan MC; Gill RK; Kim CR
    BMJ Sex Reprod Health; 2022 Jul; 48(3):163-168. PubMed ID: 34819315
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Practices for RhD alloimmunization prevention: a vignette-based survey of midwives.
    Jourdren G; Berveiller P; Rousseau A
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):7629-7639. PubMed ID: 34433367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rhesus D factor (RhD) negative women's experiences with pregnancy: An interpretive description.
    Fyfe TM; Lavoie JG; Payne GW; Banner D
    Women Birth; 2020 Nov; 33(6):e511-e518. PubMed ID: 32035799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Misoprostol: off-label use in the first trimester of pregnancy (spontaneous abortion, and voluntary medical termination of pregnancy)].
    Beucher G; Dolley P; Carles G; Salaun F; Asselin I; Dreyfus M
    J Gynecol Obstet Biol Reprod (Paris); 2014 Feb; 43(2):123-45. PubMed ID: 24433988
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management and prevention of red cell alloimmunization in pregnancy: a systematic review.
    Moise KJ; Argoti PS
    Obstet Gynecol; 2012 Nov; 120(5):1132-9. PubMed ID: 23090532
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [French guidelines for diagnostic criteria for nonviable pregnancy early in the first trimester and for management of threatened miscarriage and nonviable pregnancy (except uterine evacuation)].
    Lavoué V; Huchon C; Deffieux X; Voltzenlogel MC; Vandenbroucke L; Levêque J
    J Gynecol Obstet Biol Reprod (Paris); 2014 Dec; 43(10):776-93. PubMed ID: 25447361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estimating the cost of Rh testing and prophylaxis in early pregnancy: A time-driven activity-based costing study.
    Gilmore EV; Russell LB; Harvie HS; Schreiber CA
    Contraception; 2024 Aug; 136():110468. PubMed ID: 38648923
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-D administration in pregnancy for preventing Rhesus alloimmunisation.
    Crowther CA; Middleton P; McBain RD
    Cochrane Database Syst Rev; 2013 Feb; (2):CD000020. PubMed ID: 23450526
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Society for Maternal-Fetal Medicine Statement: RhD immune globulin after spontaneous or induced abortion at less than 12 weeks of gestation.
    ; Prabhu M; Louis JM; Kuller JA;
    Am J Obstet Gynecol; 2024 May; 230(5):B2-B5. PubMed ID: 38417536
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Economic analysis of foregoing Rh immunoglobulin for bleeding in pregnancy <12 weeks gestation.
    Horvath S; Wang L; Calo W; Yazer MH
    Contraception; 2024 Nov; 139():110530. PubMed ID: 38906503
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors for RhD immunisation despite antenatal and postnatal anti-D prophylaxis.
    Koelewijn JM; de Haas M; Vrijkotte TG; van der Schoot CE; Bonsel GJ
    BJOG; 2009 Sep; 116(10):1307-14. PubMed ID: 19538414
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prophylactic anti-D for RhD- patient in France: an hasty recommendation?].
    Benachi A; Nisand I
    J Gynecol Obstet Biol Reprod (Paris); 2007 Oct; 36(6):523-5. PubMed ID: 17651919
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.